User profiles for P. Olivier

Patrick Olivier

Action Lab, Monash University
Verified email at monash.edu
Cited by 18472

Low-temperature electrolysis system modelling: A review

P Olivier, C Bourasseau, PB Bouamama - Renewable and Sustainable …, 2017 - Elsevier
This review provides an exhaustive and comprehensive analysis of the existing modelling
works about low temperature electrolysis system: alkaline and proton exchange membrane (…

[HTML][HTML] A randomized, dose–response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration …

…, P Strang, AK Aksnes, L Franzèn, P Olivier… - European journal of …, 2012 - Elsevier
PURPOSE: To investigate the dose–response relationship and pain-relieving effect of
radium-223, a highly bone-targeted alpha-pharmaceutical. METHODS: One hundred patients with …

Bone metastases from differentiated thyroid carcinoma

MM Muresan, P Olivier, J Leclere… - Endocrine-related …, 2008 - erc.bioscientifica.com
The presence of distant metastases from differentiated thyroid carcinoma decreases the 10-year
survival of patients by 50%. Bone metastases represent a frequent complication …

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma

…, L Obéric, C Bodet-Milin, P Bories, P Olivier… - Blood …, 2020 - ashpublications.org
Chimeric antigen receptor (CAR) T-cell therapy has emerged as an option for relapsed/refractory
aggressive B-cell lymphomas that have failed 2 lines of therapy. Failures usually occur …

Omitting radiotherapy in early positron emission tomography–negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: clinical …

…, PJ Lugtenburg, E Abruzzese, P Olivier… - Journal of clinical …, 2014 - ascopubs.org
Purpose Combined-modality treatment is standard treatment for patients with clinical stage I/II
Hodgkin lymphoma (HL). We hypothesized that an early positron emission tomography (…

Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer

…, PJ Ell, RE Coleman, JA Kotler, LM Freeman, P Olivier… - Urology, 2004 - Elsevier
OBJECTIVES: A Phase III randomized trial was designed to assess the effectiveness of
samarium-153 ( 153 Sm)-lexidronam for palliation of bone pain in patients with hormone-…

Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav

…, SE Shoelson, J McGlade, P Olivier… - … and cellular biology, 1994 - Taylor & Francis
Src homology 2 (SH2) domains provide specificity to intracellular signaling by binding to
specific phosphotyrosine (phospho-Tyr)-containing sequences. We recently developed a …

[HTML][HTML] The p21Cip1 and p27Kip1 CDK 'inhibitors' are essential activators of cyclin D‐dependent kinases in murine fibroblasts

M Cheng, P Olivier, JA Diehl, M Fero… - The EMBO …, 1999 - embopress.org
The widely prevailing view that the cyclin‐dependent kinase inhibitors (CKIs) are solely negative
regulators of cyclin‐dependent kinases (CDKs) is challenged here by observations that …

[HTML][HTML] Large scale population assessment of physical activity using wrist worn accelerometers: the UK biobank study

A Doherty, D Jackson, N Hammerla, T Plötz, P Olivier… - PloS one, 2017 - journals.plos.org
… Given the size of this dataset, almost all of our findings show robust statistical significance
(p<0.001). We therefore do not report such small p-values. Box plots were used to show …

[HTML][HTML] Accuracy of the Microsoft Kinect sensor for measuring movement in people with Parkinson's disease

B Galna, G Barry, D Jackson, D Mhiripiri, P Olivier… - Gait & posture, 2014 - Elsevier
… A p < 05 was used to guide interpretation. … p refers to the repeated measures t-test to assess
bias between the … p refers to the repeated measures t-test to assess bias between the two …